StockData
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO.B) stock

BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)

Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –

Bio-Rad Laboratories gross margin

Gross margin is gross profit as a percentage of revenue.

Bio-Rad Laboratories's gross margin for the twelve months ending Jun 30, 2026 was 51.9%. For fiscal 2025 it was 51.9%, against 53.7% the year before. The highest annual figure on record is 56.9% in fiscal 2011.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202551.9%−1.9
FY2024Dec 31, 202453.7%+0.3
FY2023Dec 31, 202353.4%−2.5
FY2022Dec 31, 202255.9%−0.1
FY2021Dec 31, 202156.1%−0.4
FY2020Dec 31, 202056.5%+2.1
FY2019Dec 31, 201954.4%+0.9
FY2018Dec 31, 201853.4%−1.6
FY2017Dec 31, 201755.0%−0.1
FY2016Dec 31, 201655.0%−0.5
FY2015Dec 31, 201555.5%+1.4
FY2014Dec 31, 201454.2%−1.1
FY2013Dec 31, 201355.3%−0.6
FY2012Dec 31, 201255.8%−1.0
FY2011Dec 31, 201156.9%+0.2
FY2010Dec 31, 201056.6%+0.6
FY2009Dec 31, 200956.0%+1.5
FY2008Dec 31, 200854.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202653.1%+0.1
Q1 FY2026Mar 31, 202652.3%−0.0
Q4 FY2025Dec 31, 202549.8%−1.4
Q3 FY2025Sep 30, 202552.6%−2.2
Q2 FY2025Jun 30, 202553.0%−2.6
Q1 FY2025Mar 31, 202552.3%−1.1
Q4 FY2024Dec 31, 202451.2%−2.5
Q3 FY2024Sep 30, 202454.8%+1.7
Q2 FY2024Jun 30, 202455.6%+2.4
Q1 FY2024Mar 31, 202453.4%−0.2
Q4 FY2023Dec 31, 202353.8%−0.6
Q3 FY2023Sep 30, 202353.1%−1.6
Q2 FY2023Jun 30, 202353.2%−3.9
Q1 FY2023Mar 31, 202353.5%−4.0
Q4 FY2022Dec 31, 202254.4%−0.2
Q3 FY2022Sep 30, 202254.7%−3.7
Q2 FY2022Jun 30, 202257.2%+1.1
Q1 FY2022Mar 31, 202257.5%+2.4
Q4 FY2021Dec 31, 202154.6%−3.7
Q3 FY2021Sep 30, 202158.4%+1.7
Q2 FY2021Jun 30, 202156.0%+1.5
Q1 FY2021Mar 31, 202155.1%−0.4
Q4 FY2020Dec 31, 202058.3%+5.3
Q3 FY2020Sep 30, 202056.7%+2.0
Q2 FY2020Jun 30, 202054.6%+0.8
Q1 FY2020Mar 31, 202055.5%−0.8
Q4 FY2019Dec 31, 201952.9%−1.0
Q3 FY2019Sep 30, 201954.8%+2.2
Q2 FY2019Jun 30, 201953.8%+1.4
Q1 FY2019Mar 31, 201956.3%+1.5
Q4 FY2018Dec 31, 201853.9%−1.6
Q3 FY2018Sep 30, 201852.6%−3.4
Q2 FY2018Jun 30, 201852.4%−1.8
Q1 FY2018Mar 31, 201854.8%+0.8
Q4 FY2017Dec 31, 201755.6%+0.5
Q3 FY2017Sep 30, 201756.0%+1.0
Q2 FY2017Jun 30, 201754.2%–
Q1 FY2017Mar 31, 201754.0%–
Q4 FY2016Dec 31, 201655.0%–
Q3 FY2016Sep 30, 201654.9%–

More Bio-Rad Laboratories figures